Genmab — September 2019
-
Ok.
-
-
Tak Bulder. Ofa kan vel sammen med Ponesimod tage en del af af det beløb på bedre data og bivirkningsprofil.
-
Med 10% har du så valgt det laveste tal, når nu det er oplyst at tallet er to-cifret.

-
Jeg husker blot tal fra Medwatch: "Det er ikke officielt blevet nærmere defineret, men erhvervsmediet Finans har tidligere skrevet, at andelen ligger i spændet 12-15 pct."
-
Men her er de 2 pct nok ikke fraregnet.
-
Tak Bulder og Sukker.
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind